Innovator IBD 50 ETF (NYSEARCA:FFTY – Get Free Report) was the recipient of a significant growth in short interest in the month of August. As of August 31st, there was short interest totaling 31,675 shares, a growth of 169.8% from the August 15th total of 11,741 shares. Currently, 1.5% of the company’s shares are sold short. Based on an average daily volume of 17,743 shares, the days-to-cover ratio is currently 1.8 days.
Institutional Trading of Innovator IBD 50 ETF
Large investors have recently modified their holdings of the company. NewEdge Advisors LLC bought a new stake in Innovator IBD 50 ETF during the 1st quarter valued at $306,000. Bank of America Corp DE increased its stake in shares of Innovator IBD 50 ETF by 307.2% during the second quarter. Bank of America Corp DE now owns 12,448 shares of the company’s stock valued at $404,000 after buying an additional 9,391 shares during the period. JPMorgan Chase & Co. bought a new stake in shares of Innovator IBD 50 ETF in the third quarter valued at about $478,000. BNP Paribas Financial Markets bought a new stake in shares of Innovator IBD 50 ETF in the third quarter valued at about $1,494,000. Finally, Prosperity Wealth Management Inc. purchased a new stake in Innovator IBD 50 ETF in the third quarter worth about $637,000.
Innovator IBD 50 ETF Price Performance
FFTY stock opened at $35.24 on Friday. Innovator IBD 50 ETF has a 12 month low of $31.61 and a 12 month high of $44.08. The firm’s 50-day moving average is $37.51 and its 200 day moving average is $38.31. The company has a market capitalization of $75.77 million, a PE ratio of 30.34 and a beta of 1.45.
About Innovator IBD 50 ETF
The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.
See Also
- Five stocks we like better than Innovator IBD 50 ETF
- Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
- Optical Cable Corporation Is Starting to Get the Market’s Attention
- Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
- Is Nike’s Index Demotion a Warning or a Buying Opportunity?
Receive News & Ratings for Innovator IBD 50 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD 50 ETF and related companies with MarketBeat.com's FREE daily email newsletter.
